Skip to content

REGEN BIOPHARMA, INC.: 10-Q filed 2019-10-24

What REGEN BIOPHARMA, INC. reported in its quarterly report filed 2019-10-24 (fiscal Q3 2019): 27 published measures, 82 facts as tagged in accession 0001607062-19-000407.

This filing

Form
10-Q (quarterly report)
Filed
2019-10-24
Fiscal period
fiscal Q3 2019
Accession
0001607062-19-000407 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All REGEN BIOPHARMA, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2019-06-30114,304USD
At 2018-09-30209,018USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2019-06-3012,900,392USD
At 2018-09-309,330,689USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2019-06-30-12,801,730USD
At 2018-09-30-9,121,671USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2019-06-301,812USD
At 2018-09-308,019USD
At 2018-06-3055,404USD
At 2017-09-30269,973USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2019-04-01 to 2019-06-30-4,405,083USD91
2018-10-01 to 2019-06-30-4,486,687USD273
2018-04-01 to 2018-06-30-107,596USD91
2017-10-01 to 2018-06-30-3,733,598USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2018-10-01 to 2019-06-30-344,829USD273
2017-10-01 to 2018-06-30-1,112,200USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2019-04-01 to 2019-06-3027,425USD91
2018-10-01 to 2019-06-3082,274USD273
2018-04-01 to 2018-06-30100,000USD91
2017-10-01 to 2018-06-30100,000USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2018-10-01 to 2019-06-30288,763USD273
2017-10-01 to 2018-06-30903,372USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2018-10-01 to 2019-06-3049,858USD273
2017-10-01 to 2018-06-30-5,741USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2019-06-30-21,861,598USD
At 2018-09-30-17,457,044USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2019-04-01 to 2019-06-3085,870,761shares91
2018-10-01 to 2019-06-30330,314,986shares273
2018-04-01 to 2018-06-30153,505,198shares91
2017-10-01 to 2018-06-30148,379,644shares273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2019-04-01 to 2019-06-30-137,720USD91
2018-10-01 to 2019-06-30-567,347USD273
2018-04-01 to 2018-06-30-125,234USD91
2017-10-01 to 2018-06-30-1,162,491USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2019-06-3045,361USD
At 2018-09-3042,771USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2019-04-01 to 2019-06-3070,685USD91
2018-10-01 to 2019-06-30209,110USD273
2018-04-01 to 2018-06-3063,618USD91
2017-10-01 to 2018-06-30194,093USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2019-06-3012,367,719USD
At 2018-09-308,673,511USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2019-06-3094,548USD
At 2018-09-3080,567USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2019-06-3043,460USD
At 2018-09-300USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2019-04-01 to 2019-06-3015,328USD91
2018-10-01 to 2019-06-3023,268USD273
2018-04-01 to 2018-06-3010,355USD91
2017-10-01 to 2018-06-30340,388USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2019-06-30518,452,006shares
At 2018-09-30180,315,107shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2019-06-308,240,724USD
At 2018-09-307,517,888USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2019-06-300USD
At 2018-09-3052,948USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2019-06-30-12,786,088USD
At 2019-03-31-8,814,475USD
At 2018-12-31-8,656,832USD
At 2018-09-30-9,121,671USD
At 2018-06-30-8,567,198USD
At 2018-03-31-8,546,711USD
At 2017-12-31-7,800,232USD
At 2017-09-30-5,251,335USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2019-04-01 to 2019-06-30-4,405,083USD91
2019-01-01 to 2019-03-31-331,590USD90
2018-10-01 to 2018-12-31249,986USD92
2018-04-01 to 2018-06-30-107,596USD91
2018-01-01 to 2018-03-31-840,851USD90
2017-10-01 to 2017-12-31-2,785,149USD92

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2019-04-01 to 2019-06-30-4,409,874USD91
2018-10-01 to 2019-06-30-4,493,978USD273
2018-04-01 to 2018-06-30-107,596USD91
2017-10-01 to 2018-06-30-3,733,598USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2019-04-01 to 2019-06-30111,292USD91
2018-10-01 to 2019-06-30396,708USD273
2018-04-01 to 2018-06-30172,626USD91
2017-10-01 to 2018-06-30570,867USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2018-10-01 to 2019-06-30-43,460USD273
2017-10-01 to 2018-06-300USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2018-10-01 to 2019-06-3013,977USD273
2017-10-01 to 2018-06-30-422,455USD273

Inspect the source

Entity
REGEN BIOPHARMA, INC. / CIK 0001589150
Captured
2026-09-20T09:23:48.532Z
SEC response SHA-256
0bbe246b6080c7701ba978807745a4ba9de62971ab4db32e8d3e2fa2c4f26a87

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001589150.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))